Please provide your email address to receive an email when new articles are posted on . HOUSTON — A personalized alert tool may improve use of angiotensin-converting enzyme inhibitors and angiotensin ...

Boston, MA - A new study shows a significant reduction in the incidence of Alzheimer's disease and dementia among subjects taking angiotensin-receptor blockers (ARBs), compared with those taking ACE ...

No significant interactions were seen between ACEi or ARB treatment and age, estimated glomerular filtration rate, albuminuria, or diabetes. HealthDay News — For individuals with advanced chronic ...

Investigators studied response to standard chronic kidney disease (CKD) therapies among real-world patients with monogenic forms of glomerular disease.

Initiation of ACEi or ARB therapy reduces the risk for kidney failure, but does not appear to prolong overall survival in patients with advanced CKD. In patients with advanced chronic kidney disease ...

Toronto, ON - A new meta-analysis comparing angiotensin receptor blockers (ARBs) to placebo or ACE inhibitors in heart failure patients "cannot claim that ARBs are superior" to ACE inhibitors in ...

Please provide your email address to receive an email when new articles are posted on . Patients with advanced chronic kidney disease may benefit from use of angiotensin-converting enzyme inhibitors ...

A multicenter phase II study of first-line modified FOLFIRINOX in patients with advanced urachal cancer (ULTIMA; KCSG GU20-03). The impact of neoadjuvant chemotherapy relative dose intensity on ...

Since the introduction of ARBs, the question that has pervaded each clinician’s mind is whether or not these drugs serve an advantage in conditions long addressed by ACE inhibitors. Matchar et al ...

High blood pressure can be managed with several medication classes, each with unique benefits, side effects, and costs. From ARBs and ACE inhibitors to beta blockers and calcium channel blockers, the ...